MedX Health (TSE:MDX) has released an update.
MedX Health Corp. has announced its intention to extend the deadline for its non-brokered Private Placement offering up to an additional 30 days, pending TSX-V acceptance. The offering aims to raise $2 million by selling units consisting of one common share and one purchase warrant, each priced at $0.07, with potential for agent commissions. MedX is a medical device and software company known for its innovative skin health technologies, including the SIAscopy on DermSecure telemedicine platform.
For further insights into TSE:MDX stock, check out TipRanks’ Stock Analysis page.
